By Product
Currency:CNY
2025/FY
2025/FY
2025/H1
2024/FY
2024/H1
2023/FY
2023/H1
2022/FY
2022/H1
2021/FY
2021/H1
2020/FY
2020/H1
2019/FY
2019/H1
2018/FY
2018/H1
2017/FY
2017/H1
2016/FY
2016/H1
2015/FY
2015/H1
2014/FY
2014/H1
2013/FY
2013/H1
2012/FY
2012/H1
2011/FY
2011/H1
2010/FY
2010/H1
2009/FY
2009/H1
2008/FY
2008/H1
2007/FY
2007/H1
2006/FY
2006/H1
2005/FY
2005/H1
2004/FY
2004/H1
2003/FY
2003/H1
2002/FY
2002/H1
2001/FY
2000/FY
Stock NameRevenueRatio
Other varieties241.38M29.04%
Changwei Kang200.05M24.07%
medical service170.17M20.47%
APIs and intermediates116.8M14.05%
Cephalosporins series91.13M10.96%
Other business11.66M1.40%
View all
By Industry
Currency:CNY
2025/FY
2025/FY
2025/H1
2024/FY
2024/H1
2023/FY
2023/H1
2022/FY
2022/H1
2021/FY
2021/H1
2020/FY
2020/H1
2019/FY
2019/H1
2018/FY
2018/H1
2017/FY
2017/H1
2016/FY
2016/H1
2015/FY
2015/H1
2014/FY
2014/H1
2013/FY
2013/H1
2012/FY
2012/H1
2011/FY
2011/H1
2010/FY
2010/H1
2009/FY
2009/H1
2008/FY
2008/H1
2007/FY
2007/H1
2006/FY
2006/H1
2005/FY
2005/H1
2004/FY
2004/H1
2003/FY
2003/H1
2002/FY
2001/FY
Stock NameRevenueRatio
medicine649.35M78.12%
medical service170.17M20.47%
Other business11.66M1.40%
By Country/Region
Currency:CNY
2025/FY
2025/FY
2025/H1
2024/FY
2024/H1
2023/FY
2023/H1
2022/FY
2022/H1
2021/FY
2021/H1
2020/FY
2020/H1
2019/FY
2019/H1
2018/FY
2018/H1
2017/FY
2017/H1
2016/FY
2016/H1
2015/FY
2015/H1
2014/FY
2014/H1
2013/FY
2013/H1
2012/FY
2012/H1
2011/FY
2011/H1
2010/FY
2010/H1
2009/FY
2009/H1
2008/FY
2008/H1
2007/FY
2007/H1
2006/FY
2006/H1
2005/FY
2005/H1
2004/FY
2004/H1
2003/FY
2003/H1
2002/FY
2001/FY
2000/FY
Stock NameRevenueRatio
Domestic764.59M91.99%
Abroad66.59M8.01%
